Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Patricia S. Vassallu"'
Autor:
Anne Hagemeijer, Paula G. Heller, Felisa C. Molinas, Patricia S. Vassallu, Irene Larripa, Patricia Gargallo, Laura I. Kornblihtt
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
We report a case of essential thrombocythemia (ET) in a 39-year-old woman who developed myelofibrosis at follow-up. The cytogenetic and fluorescence in situ hybridization analyses revealed a pathologic clone with the following previously unreported k
Autor:
Paula G. Heller, Laura I. Kornblihtt, Patricia S. Vassallu, G Correa, Judith Sarano, Valeria Genoud, L. Kordich, Felisa C. Molinas, Mercedes Castañon
Publikováno v:
Thrombosis Research. 112:131-135
L.I. Kornblihtt, P.G. Heller, G. Correa, M. Castanon, V. Genoud, P. Vassallu, J. Sarano, L. Kordich, F.C. Molinas* Seccion Hematologia Investigacion, Instituto de Investigaciones Medicas Alfredo Lanari, Facultad de Medicina, Universidad de Buenos Air
Autor:
Paula G. Heller, Nora Paula Goette, Patricia S. Vassallu, Juan P. Salim, Rosana F. Marta, Ana C. Glembotsky, Paola Roxana Lev, Laura I. Kornblihtt, Felisa C. Molinas, Carlos D. Chazarreta
Publikováno v:
European journal of haematology. 77(3)
Objective: JAK2V617F mutation rate in granulocytes from essential thrombocythemia (ET) patients ranges from 12% to 57%. Our aim was to evaluate the frequency of this mutation in the megakaryocyte/platelet lineage, and to analyze its clinical associat
Publikováno v:
Medicina. 62(3)
Essential thrombocythemia (ET) is a chronic myeloproliferative syndrome characterized by thrombocythemia and increased megakaryocytes in bone marrow, thrombosis and/or hemorrhagic manifestations. We report here a ten-year experience in the treatment
Autor:
Rosana F. Marta, Patricia S. Vassallu, Laura I. Kornblihtt, Daniel C. Chazarreta, Juan P. Salim, Ana C. Glembotsky, Paula G. Heller, Paola Roxana Lev, Felisa C. Molinas, Nora Paula Goette
Publikováno v:
Blood. 106:4972-4972
The JAK2V617F mutation has been recently reported in patients with polycythemia vera (PV) and a proportion of patients with ET and myelofibrosis with myeloid metaplasia. This acquired point mutation constitutively activates JAK2 tyrosine kinase and i
Autor:
Maria Susana Laguna, Paola Roxana Lev, Rosana F. Marta, Laura I. Kornblihtt, Ana C. Glembotsky, Paula G. Heller, Nora Paula Goette, Daniel C. Chazarreta, Patricia S. Vassallu, Juan P. Salim, Felisa C. Molinas
Publikováno v:
Blood. 106:4970-4970
Introduccion: Patients with essential thrombocythemia (ET) may have abnormalities of platelet function (PF), the most frecuently are reduced response to epinephrine and ADP-induced aggregation and spontaneous aggregation. Anagrelide (A) has a phospho